0001415889-23-003569.txt : 20230228 0001415889-23-003569.hdr.sgml : 20230228 20230228201732 ACCESSION NUMBER: 0001415889-23-003569 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230226 FILED AS OF DATE: 20230228 DATE AS OF CHANGE: 20230228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAY SUSANNAH CENTRAL INDEX KEY: 0001833453 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36033 FILM NUMBER: 23689009 MAIL ADDRESS: STREET 1: 10770 WATERIDGE CIRCLE SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theravance Biopharma, Inc. CENTRAL INDEX KEY: 0001583107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 650-808-6000 MAIL ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 4 1 form4-03012023_010311.xml X0306 4 2023-02-26 0001583107 Theravance Biopharma, Inc. TBPH 0001833453 GRAY SUSANNAH C/O THERAVANCE BIOPHARMA US, INC. SOUTH SAN FRANCISCO CA 94080 true false false false Ordinary Shares 2023-02-26 4 A 0 10131 0 A 10131 D Ordinary Shares 2023-02-26 4 A 0 1688 0 A 11819 D Share Option (Right to Buy) 9.87 2023-02-26 4 A 0 28000 0 A 2033-02-25 Ordinary Shares 28000 28000 D Share Option (Right to Buy) 9.87 2023-02-26 4 A 0 4666 0 A 2033-02-25 Ordinary Shares 4666 4666 D The option vests monthly over 24 months of service from the date of grant. This option shall vest monthly over two months of service from the date of grant and will vest in full upon earlier of the two-month anniversary of Susannah Gray's appointment to the Board or the date of Company's 2023 annual meeting of Shareholders. /s/ Brett A. Grimaud, Attorney-in-Fact 2023-02-28